Current Understanding of Resistance to Abiraterone and Enzalutamide in Advanced Prostate Cancer

被引：0
|
作者：
Antonarakis, Emmanuel S. [1 ]
机构：
[1] Johns Hopkins Sidney Kimmel Comprehens Canc Ctr, Oncol & Urol, Baltimore, MD 21287 USA
来源：
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | 2016年 / 14卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：316 / 319
页数：4
相关论文
共 50 条
  • [1] Understanding and overcoming the mechanisms of primary and acquired resistance to abiraterone and enzalutamide in castration resistant prostate cancer
    Buttigliero, Consuelo
    Tucci, Marcello
    Bertaglia, Valentina
    Vignani, Francesca
    Bironzo, Paolo
    Di Maio, Massimo
    Scagliotti, Giorgio Vittorio
    CANCER TREATMENT REVIEWS, 2015, 41 (10) : 884 - 892
  • [2] Survival of veterans treated with enzalutamide and abiraterone in advanced prostate cancer.
    Schoen, Martin W.
    Carson, Kenneth Robert
    Luo, Suhong
    Eisen, Seth
    Reimers, Melissa Andrea
    Drake, Bettina F.
    Bennett, Charles L.
    Knoche, Eric Marshall
    Yan, Yan
    Sanfilippo, Kristen Marie
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [3] AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
    Antonarakis, Emmanuel S.
    Lu, Changxue
    Wang, Hao
    Luber, Brandon
    Nakazawa, Mary
    Roeser, Jeffrey C.
    Chen, Yan
    Mohammad, Tabrez A.
    Chen, Yidong
    Fedor, Helen L.
    Lotan, Tamara L.
    Zheng, Qizhi
    De Marzo, Angelo M.
    Isaacs, John T.
    Isaacs, William B.
    Nadal, Rosa
    Paller, Channing J.
    Denmeade, Samuel R.
    Carducci, Michael A.
    Eisenberger, Mario A.
    Luo, Jun
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (11): : 1028 - 1038
  • [4] Abiraterone or Enzalutamide in Advanced Castration-Resistant Prostate Cancer: An Indirect Comparison
    Chopra, Akhil
    Georgieva, Mina
    Lopes, Gilberto
    Yeo, Chong Ming
    Haaland, Benjamin
    PROSTATE, 2017, 77 (06): : 639 - 646
  • [5] The Cardiovascular Toxicity of Abiraterone and Enzalutamide in Prostate Cancer
    Iacovelli, Roberto
    Ciccarese, Chiara
    Bria, Emilio
    Romano, Mario
    Fantinel, Emanuela
    Bimbatti, Davide
    Muraglia, Alessandro
    Porcaro, Antonio Benito
    Siracusano, Salvatore
    Brunelli, Matteo
    Mazzarotto, Renzo
    Artibani, Walter
    Tortora, Giampaolo
    CLINICAL GENITOURINARY CANCER, 2018, 16 (03) : E645 - E653
  • [6] EVALUATION OF NICLOSAMIDE AS A POTENT INHIBITOR OF ANDROGEN RECEPTOR VARIANTS TO OVERCOME RESISTANCE TO ABIRATERONE AND ENZALUTAMIDE IN ADVANCED PROSTATE CANCER
    Liu, Chengfei
    Lou, Wei
    Yang, Joy
    Pan, Chong-Xian
    Lara, Primo
    Evans, Christopher
    Gao, Allen
    JOURNAL OF UROLOGY, 2017, 197 (04): : E678 - E678
  • [7] Re: AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2015, 193 (02): : 538 - 538
  • [8] Re: AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
    Anand, Aseem Undvall
    Bjartell, Anders
    EUROPEAN UROLOGY, 2015, 67 (02) : 349 - 350
  • [9] Identifying serum biomarkers for predicting the resistance of enzalutamide or abiraterone in prostate cancer patients
    Chuu, Chihpin
    Lin, Tzuping
    Huo, Chieh
    CANCER SCIENCE, 2024, 115 : 329 - 329
  • [10] Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer
    Annala, Matti
    Vandekerkhove, Gillian
    Khalaf, Daniel
    Taavitsainen, Sinja
    Beja, Kevin
    Warner, Evan W.
    Sunderland, Katherine
    Kollmannsberger, Christian
    Eigl, Bernhard J.
    Finch, Daygen
    Oja, Conrad D.
    Vergidis, Joanna
    Zulfiqar, Muhammad
    Azad, Arun A.
    Nykter, Matti
    Gleave, Martin E.
    Wyatt, Alexander W.
    Chi, Kim N.
    CANCER DISCOVERY, 2018, 8 (04) : 444 - 457
12345